Page 54 - GALENIKA MEDICAL JOURNAL
P. 54

i saradnika pokazano je da je došlo do histološke regresije   Takođe, kod pacijenata kod kojih je nakon SG neophodna
          BE godinu dana nakon RYGBP kod skoro 50% pacijenata .   revizija zbog nekontrolisanih simptoma GERD, pojave BE ili
                                                        32
          U ovoj studiji je u periodu praćenja od godinu dana verifiko-  rezistentnog erozivnog ezofagitisa, RYGBP predstavlja pro-
          vana i rezolucija refluksnog ezofagitisa kod svih pacijenata,   ceduru izbora, sa rezolucijom refluksnih tegoba kod preko
          sa rezolucijom simptoma GERD kod preko 90% bolesnika.  90% pacijenata.





          Zaključak

          Postoji jasna povezanost gojaznosti i gastroezofagealne refluksne bolesti, kako u pogledu učestalosti
          simptoma GERD, tako i u pogledu prisustva hernije hijatusa jednjaka i komplikacija GERD. Iako
          barijatrijska hirurgija ima odličan efekat na gubitak tjelesne težine i komorbiditete koji prate
          gojaznost, procjena simptoma i komplikacija GERD je esencijalna prije izbora procedure. To naravno
          podrazumijeva da je izvođenje endoskopije gornjeg digestivnog trakta apsolutno neophodno prije
          barijatrijske hirurgije. Najčešća barijatrijska procedura, sleeve gastrektomija, nosi značajan rizik za
          pogoršanje postojećeg ili nastanak de novo GERD. To se prevashodno odnosi na nedovoljno ispitane

          pacijente i neadekvatno načinjenu hiruršku intervenciju. Sa druge strane, RYGBP ima povoljan efekat
          na GERD, a ovu proceduru treba preporučiti pacijentima sa predoperativno verifikovanim GERD u
          programu barijatrijske hirurgije. Takođe, RYGBP treba razmotriti kao primarni vid liječenja bolesnika
          kod kojih je indikovana antirefluksna hirurgija, a imaju BMI preko 35 kg/m . RYGBP predstavlja i prvi
                                                                                  2
          izbor za reviziju nakon SG zbog nekontrolisanih simptoma ili komplikacija GERD.






          Abstract

          The obesity pandemic is becoming one of the most significant global problems. Along with obesity, gastroesophageal reflux
          disease (GERD) is becoming the most prevalent digestive problem. The relationship between these two conditions has been
          proven - obesity directly affects the development of GERD, as well as an increase in the incidence of GERD complications. A
          particular problem arises in patients who are candidates for bariatric surgery and have proven GERD, which can result in
          postoperative reflux. The aim of this review is to highlight the interaction between these two conditions and present the
          results of bariatric surgery in the context of evaluating reflux disease before and after the bariatric procedure.

          Keywords: obesity, gastroesophageal reflux disease (GERD), bariatric surgery






          Literatura                                         6.  Ren CJ, Patterson E, Gagner M. Early results of laparoscopic
                                                                biliopancreatic diversion with duodenal switch: a case series of 40
                                                                consecutive patients. Obes Surg. 2000 Dec;10(6):514-23.
          1.  Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev   7.  Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011.
             Endocrinol. 2019 May;15(5):288-98.                 Obes Surg. 2013 Apr;23(4):427-36.
          2.  Skow MA, Bergmann NC, Knop FK. Diabetes and obesity treatment   8.  Rogers AM. Current State of Bariatric Surgery: Procedures, Data, and
             based on dual incretin receptor activation: 'twincretins'. Diabetes Obes   Patient Management. Tech Vasc Interv Radiol. 2020 Mar;23(1):100654.
             Metab. 2016 Sep;18(9):847-54.
                                                             9.  Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The Changing
          3.  Perez-Montes DE Oca A, Pellitero S, Puig-Domingo M. Obesity and GLP-  Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting
             1. Minerva Endocrinol (Torino). 2021 Jun;46(2):168-76.  Younger? J Neurogastroenterol Motil. 2018 Oct 1;24(4):559-69.
          4.  Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967   10.  Pandolfino JE. The relationship between obesity and GERD: "big or
             Dec;47(6):1345-51.                                 overblown". Am J Gastroenterol. 2008 Jun;103(6):1355-7.
          5.  Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic Gastric Bypass,   11.  Vaezi MF. GERD and obesity: a real BIG issue! Gastroenterology. 2008
             Roux-en-Y: Preliminary Report of Five Cases. Obes Surg. 1994   Mar;134(3):882-3.
             Nov;4(4):353-7.



          52     DOI: 10.5937/Galmed2306048S
   49   50   51   52   53   54   55   56   57   58   59